vs

Side-by-side financial comparison of Bristol Myers Squibb (BMY) and PLAINS ALL AMERICAN PIPELINE LP (PAA). Click either name above to swap in a different company.

Bristol Myers Squibb is the larger business by last-quarter revenue ($11.5B vs $10.0B, roughly 1.1× PLAINS ALL AMERICAN PIPELINE LP). Bristol Myers Squibb runs the higher net margin — 23.3% vs 3.4%, a 19.9% gap on every dollar of revenue. On growth, Bristol Myers Squibb posted the faster year-over-year revenue change (11.0% vs -19.1%). Over the past eight quarters, Bristol Myers Squibb's revenue compounded faster (-3.0% CAGR vs -8.6%).

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid art...

Plains is a master limited partnership engaged in pipeline transport, marketing, and storage of liquefied petroleum gas and petroleum in the United States and Canada. Plains owns interests in 18,370 miles (29,560 km) of pipelines, storage capacity for about 75 million barrels of crude oil, 28 million barrels of NGLs, 68 billion cubic feet of natural gas, and 5 natural gas processing plants. The company is headquartered in the Allen Center in Downtown Houston, Texas. Plains is a publicly trade...

BMY vs PAA — Head-to-Head

Bigger by revenue
BMY
BMY
1.1× larger
BMY
$11.5B
$10.0B
PAA
Growing faster (revenue YoY)
BMY
BMY
+30.1% gap
BMY
11.0%
-19.1%
PAA
Higher net margin
BMY
BMY
19.9% more per $
BMY
23.3%
3.4%
PAA
Faster 2-yr revenue CAGR
BMY
BMY
Annualised
BMY
-3.0%
-8.6%
PAA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BMY
BMY
PAA
PAA
Revenue
$11.5B
$10.0B
Net Profit
$2.7B
$341.0M
Gross Margin
7.0%
Operating Margin
1.8%
Net Margin
23.3%
3.4%
Revenue YoY
11.0%
-19.1%
Net Profit YoY
8.8%
847.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMY
BMY
PAA
PAA
Q1 26
$11.5B
Q4 25
$12.5B
$10.0B
Q3 25
$12.2B
$11.6B
Q2 25
$12.3B
$10.6B
Q1 25
$11.2B
$12.0B
Q4 24
$12.3B
$12.4B
Q3 24
$11.9B
$12.7B
Q2 24
$12.2B
$12.9B
Net Profit
BMY
BMY
PAA
PAA
Q1 26
$2.7B
Q4 25
$1.1B
$341.0M
Q3 25
$2.2B
$441.0M
Q2 25
$1.3B
$210.0M
Q1 25
$2.5B
$443.0M
Q4 24
$72.0M
$36.0M
Q3 24
$1.2B
$220.0M
Q2 24
$1.7B
$250.0M
Gross Margin
BMY
BMY
PAA
PAA
Q1 26
Q4 25
67.2%
7.0%
Q3 25
71.9%
8.6%
Q2 25
72.5%
8.3%
Q1 25
72.9%
10.4%
Q4 24
61.0%
9.5%
Q3 24
75.1%
9.3%
Q2 24
73.2%
8.3%
Operating Margin
BMY
BMY
PAA
PAA
Q1 26
Q4 25
11.8%
1.8%
Q3 25
25.5%
4.2%
Q2 25
14.5%
2.2%
Q1 25
26.5%
4.4%
Q4 24
1.4%
0.7%
Q3 24
14.1%
2.7%
Q2 24
10.5%
2.9%
Net Margin
BMY
BMY
PAA
PAA
Q1 26
23.3%
Q4 25
8.7%
3.4%
Q3 25
18.0%
3.8%
Q2 25
10.7%
2.0%
Q1 25
21.9%
3.7%
Q4 24
0.6%
0.3%
Q3 24
10.2%
1.7%
Q2 24
13.8%
1.9%
EPS (diluted)
BMY
BMY
PAA
PAA
Q1 26
Q4 25
$0.54
Q3 25
$1.08
Q2 25
$0.64
Q1 25
$1.20
Q4 24
$0.05
Q3 24
$0.60
Q2 24
$0.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMY
BMY
PAA
PAA
Cash + ST InvestmentsLiquidity on hand
$9.6B
$328.0M
Total DebtLower is stronger
$-42.2B
$10.7B
Stockholders' EquityBook value
Total Assets
$30.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMY
BMY
PAA
PAA
Q1 26
$9.6B
Q4 25
$10.2B
$328.0M
Q3 25
$15.7B
$1.2B
Q2 25
$12.6B
$459.0M
Q1 25
$10.9B
$427.0M
Q4 24
$10.3B
$348.0M
Q3 24
$7.9B
$640.0M
Q2 24
$6.3B
$553.0M
Total Debt
BMY
BMY
PAA
PAA
Q1 26
$-42.2B
Q4 25
$44.8B
$10.7B
Q3 25
$48.7B
$8.4B
Q2 25
$48.9B
$8.2B
Q1 25
$49.5B
$8.2B
Q4 24
$49.4B
$7.2B
Q3 24
$49.5B
$7.2B
Q2 24
$52.0B
$7.2B
Stockholders' Equity
BMY
BMY
PAA
PAA
Q1 26
Q4 25
$18.5B
Q3 25
$18.6B
Q2 25
$17.4B
Q1 25
$17.4B
Q4 24
$16.3B
Q3 24
$17.1B
Q2 24
$17.0B
Total Assets
BMY
BMY
PAA
PAA
Q1 26
Q4 25
$90.0B
$30.2B
Q3 25
$96.9B
$28.1B
Q2 25
$94.7B
$27.2B
Q1 25
$92.4B
$27.1B
Q4 24
$92.6B
$26.6B
Q3 24
$93.7B
$27.2B
Q2 24
$94.6B
$27.5B
Debt / Equity
BMY
BMY
PAA
PAA
Q1 26
Q4 25
2.43×
Q3 25
2.63×
Q2 25
2.81×
Q1 25
2.85×
Q4 24
3.03×
Q3 24
2.89×
Q2 24
3.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMY
BMY
PAA
PAA
Operating Cash FlowLast quarter
$786.0M
Free Cash FlowOCF − Capex
$638.0M
FCF MarginFCF / Revenue
6.4%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$2.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMY
BMY
PAA
PAA
Q1 26
Q4 25
$2.0B
$786.0M
Q3 25
$6.3B
$817.0M
Q2 25
$3.9B
$694.0M
Q1 25
$2.0B
$639.0M
Q4 24
$4.4B
$727.0M
Q3 24
$5.6B
$691.0M
Q2 24
$2.3B
$653.0M
Free Cash Flow
BMY
BMY
PAA
PAA
Q1 26
Q4 25
$1.6B
$638.0M
Q3 25
$6.0B
$632.0M
Q2 25
$3.6B
$575.0M
Q1 25
$1.7B
$448.0M
Q4 24
$4.1B
$561.0M
Q3 24
$5.3B
$534.0M
Q2 24
$2.1B
$514.0M
FCF Margin
BMY
BMY
PAA
PAA
Q1 26
Q4 25
12.8%
6.4%
Q3 25
49.0%
5.5%
Q2 25
29.0%
5.4%
Q1 25
15.1%
3.7%
Q4 24
32.9%
4.5%
Q3 24
44.3%
4.2%
Q2 24
16.9%
4.0%
Capex Intensity
BMY
BMY
PAA
PAA
Q1 26
Q4 25
3.0%
1.5%
Q3 25
2.6%
1.6%
Q2 25
2.9%
1.1%
Q1 25
2.3%
1.6%
Q4 24
3.1%
1.3%
Q3 24
2.7%
1.2%
Q2 24
2.1%
1.1%
Cash Conversion
BMY
BMY
PAA
PAA
Q1 26
Q4 25
1.82×
2.30×
Q3 25
2.87×
1.85×
Q2 25
2.99×
3.30×
Q1 25
0.80×
1.44×
Q4 24
61.65×
20.19×
Q3 24
4.62×
3.14×
Q2 24
1.38×
2.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMY
BMY

Segment breakdown not available.

PAA
PAA

Products$9.6B96%
Transportation$341.0M3%
Terminalling Storage And Other$90.0M1%
Affiliated Entity$14.0M0%

Related Comparisons